Getting out of a wheelchair: an uncommon insertion mutation in exon 19 of EGFR responsive to erlotinib

BACKGROUND: Most patients with non-small cell lung cancer (NSCLC) present with advanced disease and have poor long-term prognosis. Advanced NSCLC that contains characteristic mutations in epidermal growth factor receptor (EGFR) are highly sensitive to EGFR tyrosine kinase inhibitors (TKIs). EGFR exo...

Descripción completa

Detalles Bibliográficos
Autores principales: Agbarya, Abed, Melamed-Frank, Meira, Kaidar-Person, Orit, Goldberg-Cohen, Ilana, Nasrallah, Haitam, Wollner, Mira, Bar, Jair, Rennert, Gad, Lejbkowicz, Flavio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2014
Materias:
Case Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4180504/
https://www.ncbi.nlm.nih.gov/pubmed/25279299
http://dx.doi.org/10.1186/2193-1801-3-507

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4180504/
https://www.ncbi.nlm.nih.gov/pubmed/25279299
http://dx.doi.org/10.1186/2193-1801-3-507

Ejemplares similares